Amid a big era for consolidation in the health insurance sector, will the M&A wave spur more deals?» Read More
Federal law enforcement agencies recently contacted several Herbalife members for information about their own business practices, CNBC has learned.
An estimated 3 million Americans have autism. But what exactly what is it, and where are we on treatments?
Ventas said it would buy privately held hospital chain Ardent Medical Services for $1.75 billion in cash.
An intestinal illness called Shigellosis and carried by international travelers is spreading across the U.S., according to the Centers for Disease Control and Prevention.
The new Obamacare enrollment numbers show that you can't fix stupid, says Jake Novak. But wait—he's got an idea.
The government for the first time revealed how many people have signed up for HealthCare.gov plans during a special enrollment period.
A BMW ad featuring a "crazy" lady scaring a couple is drawing heat from a mental health advocacy group that wants the ad yanked.
E-cigarettes may have been marketed as a healthier option to cigarettes, yet, a new report shows that 1 in 5 U.K. teenagers have tried them.
As gene therapy emerges in the biotech industry, one analyst explains why it could be the next billion dollar industry.
A national pharmacists' group has adopted a policy discouraging its members from providing death-penalty drugs.
CNBC's Meg Tirrell reports on health care consolidation and PBM stocks to watch.
Teva said the deal would add a portfolio of drugs for the treatment of central nervous system disorders.
Officials have yet to keep their promise to disclose how many people are signing up during a special Obamacare enrollment season.
The CEO of biotech company Genfit told CNBC that the markets are overreacting to the results of its NASH study.
How many of you who have Obamacare went to the doctor's office more often?
For biotech watchers, it's deja vu all over again. Through Wednesday, the Nasdaq Biotechnology Index dropped 6.9 percent since the close March 20.
The world is facing a serious water crisis. Former NFL star Jack Brewer highlights a couple of companies investing in solutions.
A bipartisan compromise to overhaul Medicare bucks the popular impression that Washington can't accomplish anything at all.
Investors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders.
Major pharmaceuticals companies have formed a partnership with Genomics England in the first step towards using genetic data from NHS patients.
Get the best of CNBC in your inbox